Table 4.

Summary of treatment-emergent adverse events

	Placebo (n=50)	SNG001 (n=48)
Any treatment-emergent adverse event	30 (60%)	26 (54%)
Any treatment-emergent adverse event during treatment period	25 (50%)	23 (48%)
Any serious treatment-emergent adverse event	14 (28%)	7 (15%)
Any treatment-related treatment-emergent adverse event	2 (4%)	7 (15%)
Any fatal treatment-emergent adverse event	3 (6%)	0
Any treatment-emergent adverse event that led to study withdrawal	3 (6%)	0

Data are n (%), where n corresponds to number of patients with adverse reactions.